세계의 체외 전사 템플릿 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

The global demand for In-Vitro Transcription Templates Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

In-vitro transcription templates are molecules used in the process of in-vitro transcription, which is the process of synthesizing RNA in a test tube or other laboratory setting. In-vitro transcription templates are typically DNA molecules that contain the sequence of the RNA that is to be synthesized. During in-vitro transcription, the DNA template is mixed with RNA polymerase enzymes and other components in a test tube. The RNA polymerase enzyme then reads the DNA template and synthesizes a complementary RNA molecule. The RNA molecule can then be purified and used for gene expression studies or as a tool for RNA interference. In-vitro transcription templates can be synthesized using a variety of techniques, such as chemical synthesis or PCR amplification.

Market Dynamics:

RNA-based therapies, such as RNA interference and messenger RNA therapeutics, are gaining popularity due to their potential to treat a variety of diseases. In-vitro transcription templates are a key component in the production of RNA-based therapies, and the growing demand for these therapies is driving the growth of the market. Gene editing technologies such as CRISPR-Cas9 are gaining popularity and are driving the demand for in-vitro transcription templates. In-vitro transcription templates are used in the preparation of guide RNA molecules, which are necessary for CRISPR-Cas9 gene editing. With the increasing investment in research and development in the biotechnology industry, the demand for in-vitro transcription templates is growing. Researchers are using these templates for a wide range of applications, such as gene expression studies and the development of RNA-based therapies. Advancements in the synthesis and purification of in-vitro transcription templates are driving the growth of the market. New and more efficient synthesis methods are being developed, allowing for the production of high-quality templates at lower costs. Collaborations and partnerships between academic institutions, research organizations, and biotech companies are driving the growth of the In-Vitro Transcription Templates market. These collaborations are allowing for the development of new and innovative applications for in-vitro transcription templates.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in-vitro transcription templates. The growth and trends of in-vitro transcription templates industry provide a holistic approach to this study.

Market Segmentation:

This section of the in-vitro transcription templates market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

• Cancer (Solid Tumors, Colorectal Cancer, Nsclc, Melanoma, Leukemia, Prostate Cancer, Others)
• Infectious Diseases (Influenza, COVID-19, Aids, Others)
• Lifestyle Diseases
• Genetic Diseases
• Others

By Treatment

• Vaccine
• Therapeutic

By Research Stage

• Exploratory
• Clinical

By End User

• Pharmaceutical & Biotechnology Companies
• CROs & CMOs
• Academics & Research
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the In-Vitro Transcription Templates market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• Global In-Vitro Transcription Templates Market Share by Region (Representative Graph)
• Global In-Vitro Transcription Templates Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in-vitro transcription templates market include Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences Inc., Cytiva (Danaher). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . IN-VITRO TRANSCRIPTION TEMPLATES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Disease
  • 3.7.2 Market Attractiveness Analysis By Treatment
  • 3.7.3 Market Attractiveness Analysis By Research Stage
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY DISEASE

• 5.1 Overview by Disease
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Disease
• 5.4 Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others) Historic and Forecast Sales by Regions
• 5.5 Infectious Diseases (Influenza, COVID-19, AIDS, Others) Historic and Forecast Sales by Regions
• 5.6 Lifestyle Diseases Historic and Forecast Sales by Regions
• 5.7 Genetic Diseases Historic and Forecast Sales by Regions
• 5.8 Others Historic and Forecast Sales by Regions

6 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY TREATMENT

• 6.1 Overview by Treatment
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Treatment
• 6.4 Vaccine Historic and Forecast Sales by Regions
• 6.5 Therapeutic Historic and Forecast Sales by Regions

7 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY RESEARCH STAGE

• 7.1 Overview by Research Stage
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Research Stage
• 7.4 Exploratory Historic and Forecast Sales by Regions
• 7.5 Clinical Historic and Forecast Sales by Regions

8 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY END USER

• 8.1 Overview by End User
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End User
• 8.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 8.5 CROs & CMOs Historic and Forecast Sales by Regions
• 8.6 Academics & Research Historic and Forecast Sales by Regions
• 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE IN-VITRO TRANSCRIPTION TEMPLATES COMPANIES

• 10.1. In-Vitro Transcription Templates Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF IN-VITRO TRANSCRIPTION TEMPLATES INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Promega Corporation
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Agilent Technologies Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. New England Biolabs
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Takara Bio Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Lucigen Corporation
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Enzynomics Co. Ltd.
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Enzo Life Sciences Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Cytiva (Danaher)
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies